While the massive distribution effort associated with getting the COVID-19 vaccine to the public should not be underestimated, some of the hurdles have been vastly exaggerated.
Gartner interviewed several of the largest third-party logistics (3PL) players around the globe to determine potential capacity constraints and other challenges.
This research is intended to provide logistics leaders with clarity on how the vaccine distribution may impact operations. Separate fact from fiction and explore the 5 Misconceptions Associated With the Global Distribution of the COVID-19 Vaccine.